Klemens Budde, MD
Acting Head, Dept of Medicine
Campus Mitte Charité Universitätsmedizin
Prof. Klemens Budde, MD, is a professor and head of the nephrology department with over 15 years of experience in kidney disease, research and transplantation.
Prof. Budde is Acting Head of the Department of Medicine, Nephrology, at the Campus Mitte Charite Universitatsmedizin in Berlin, Germany, where he teaches Pharmacodynamics of Immunosupression after Renal Transplantation as a full professor. He is a board-certified physician in nephrology and internal medicine.
Prof. Budde received his MD at the University Tubingen in Germany and conducted his postdoctoral fellowship in Nephrology at the Department of Internal Medicine, Yale University. He is a member of more than 15 professional societies and organizations, as well as serves on the editorial boards and conducts peer reviews for a variety of medical journals.
Dana Goldman, Ph.D.
Leonard D. Schaeffer Chair and Director
Schaeffer Center of Health Policy and Economics
University of Southern California
Dana Goldman, Ph.D., is an economist who advises numerous academic, governmental and industry organizations about health policy and its economic impact.
Dr. Goldman is the Leonard D. Schaeffer Chair in Health Policy at the Leonard D. Schaeffer Center for Health Policy and Economics at the University of Southern California.
Dr. Goldman received his Ph.D. in economics from Stanford University. His work has been published in more than 150 articles and book chapters, and he is the founding editor of the Forum for Health Economics and Policy. In addition to his work at the Leonard D. Schaeffer Center for Health Policy and Economics, he is a health policy advisor to the Congressional Budget Office, Covered California and the Fred Hutchinson Cancer Institute.
Frank E. Harrell, Jr., Ph.D.
Professor of Biostatistics, Department Chair
Vanderbilt University School of Medicine
Frank E. Harrell, Jr., Ph.D., is a professor and consultant in the areas of drug development, drug safety, clinical trials and clinical epidemiology. His primary area of expertise is clinical prediction models.
Dr. Harrell is a professor of biostatistics and Chair of the Department of Biostatistics at Vanderbilt University School of Medicine.
Dr. Harrell received his Ph.D. in biostatistics from the University of North Carolina. He has extensive experience in the study of patient outcomes and the development of accurate prognostic and diagnostic models, and his methodological research includes statistical analysis, clinical prediction, clinical trials, drug safety, graphics, predictive models and model validation.
Dr. Harrell has collaborated in designing numerous clinical, health services and patient outcomes research studies and consulted and collaborated on biomedical research projects in academia and in industry. He has published more than 217 peer-reviewed publications and has served on many academic boards and data monitoring committees.
Peter Rossing, MD
Staff Specialist, Chief Physician
Steno Diabetes Center
Prof. Rossing is a physician and professor whose primary are of expertise is diabetes, diabetic nephropathy, renal disease and cardiovascular disease.
Prof. Rossing is the Staff Specialist, Chief Physician, and Diabetes Complications Research Group Leader at the Steno Diabetes Center in Gentofte, Denmark. His is Adjunct Professor in diabetic angiopathy at Aarhus University and Professor at Copenhagen University.
Prof. Rossing received his MD from Copenhagen University Medical School, specializing in Internal Medicine and Endocrinology. He is past President of the Danish Endocrine Society, where he has been a member of the board from 2006-2016, is Chairman of the National Danish Adult Diabetes Registry. He has published more than 300 peer-reviewed publications, has presented more than 400 presentations and abstracts and serves on the numerous foundation boards and as a peer reviewer for a variety of medical journals.
Marcia A. Testa, M.P.H., Ph.D.
Senior Lecturer on Biostatistics
Harvard T.H. Chan School of Public Health
Harvard University, Boston, MA
Marcia A. Testa, M.P.H., Ph.D. is an academic scholar on health outcomes measurement, biostatistics and evaluation. Her research and teaching covers a wide range of applications, including patient-centered outcomes, comparative effectiveness research, pharmaceutical regulatory science, public health preparedness and clinical trials in several diseases and conditions, including diabetes, hypertension, cancer and HIV.
Dr. Testa received her M.P.H., M.Phil and Ph.D. in epidemiology and public health (biostatistics) from Yale University. Her primary research focuses on the development of analytical and statistical methods for measurement and analysis of patient-centered outcomes, quality of life, patient satisfaction, cost effectiveness, risk-benefit and, most recently, technology-enabled, mobile reporting and sensing for remote patient monitoring.
At Harvard, Dr. Testa has appointments in the Department of Biostatistics and Division of Policy Translation and Leadership Development, where she serves as the Director of the Harvard School of Public Health Preparedness and Emergency Response Learning Center. She is also Chairman of Phase V Technologies, Inc., and Vice Chairman of the Wellesley (MA) Board of Health. She has presented internationally and has over 120 scientific publications. See The Harvard School of Public Health Faculty and Researcher Directory for more details.